Are More Low-Risk Prostate Cancers Detected by Repeated Biopsy? A Retrospective Pilot Study

다국어 초록 (Multilingual Abstract)

Purpose: We hypothesized that there might be a higher incidence of low-risk prostate cancer (PCa) in men diagnosed at a repeated biopsy. Thus, we investigated differences in clinicopathological results of PCa after primary and repeated biopsy.
Materials and Methods: We retrospectively reviewed patients diagnosed with PCa at a primary or repeated biopsy from January 2004 to April 2011. Patients were stratified into primary biopsy and repeated biopsy groups. We analyzed prostate-specific antigen,clinical stage, Gleason score (GS), positive core ratio, and low-risk group by using D’Amico classification. We also investigated GS upgrading and upstaging after radical prostatectomy (RP).
Results: Among 448 primary and 37 repeated biopsy PCa patients, 82 (group 1) and 25 (group 2) underwent RP. The percentage of low-risk patients did not differ significantly between the groups. The positive biopsy core ratio was significantly lower in group 2 (p=0.009). The percentages of GS upgrading and upstaging were 42.7% and 47.6% in group 1, respectively (p=0.568), and 48.0% and 52.0% in group 2, respectively (p=0.901). In the analysis of low-risk patients, GS upgrading and upstaging were not significantly different between the groups (p=0.615 and p=0.959, respectively).
Conclusions: A lower positive core ratio may imply a small volume of PCa and possibly insignificant PCa in the repeated biopsy group. However, no significant differences were observed for the ratio of low-risk cancers, GS upgrading, or upstaging between the groups. Therefore, PCa diagnosed at a repeated biopsy is not an additional indication for active surveillance.

참고문헌 (Reference)

1 Djavan B, "qPredictability and significance of multifocal prostate cancer in the radical prostatectomy specimen" 5 : 139-142, 1999

2 Yanke BV, "Validation of a nomogram for predicting positive repeat biopsy for prostate cancer" 173 : 421-424, 2005

3 Epstein JI, "The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer" 162 : 1649-1652, 1999

4 Villa L, "The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer" 189 : 854-859, 2013

5 Ploussard G, "The contemporary concept of significant versus insignificant prostate cancer" 60 : 291-303, 2011

6 Tan N, "Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade" 180 : 1325-1329, 2008

7 Lopez-Corona E, "Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate" 175 (175): 923-927, 2006

8 Djavan B, "Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?" 166 : 1679-1683, 2001

9 Lane JA, "Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies" 46 : 3095-3101, 2010

10 Park M, "Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? Analysis by the number of cores taken at initial biopsy" 109 : 1474-1479, 2012

11 강인호, "Differences in Postoperative Pathological Outcomes between Prostate Cancers Diagnosed at Initial and Repeat Biopsy" 대한비뇨기과학회 53 (53): 531-535, 2012

12 Bastian PJ, "Characteristics of insignificant clinical T1c prostate tumors: a contemporary analysis" 101 : 2001-2005, 2004

13 Numao N, "Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy" 109 : 665-671, 2012

14 D'Amico AV, "Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer" 280 : 969-974, 1998

15 Liu D, "Active surveillance versus surgery for low risk prostate cancer: a clinical decision analysis" 187 : 1241-1246, 2012